BAYER CROPSCIENCE LTD. - 506285 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding loss/duplicate issue of Share Certificate. BAYER CROPSCIENCE LTD. - 506285 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please take note of the transcript of the Investor Meet of Bayer CropScience Limited held on June 03, 2022 which has been disclosed on the website of the Company at www.bayer.in as well as submitted to the Stock Exchange for dissemination and records. Earnings Call for Q4FY22 of Bayer Cropscience
Conference Call with Bayer Cropscience Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript. BAYER CROPSCIENCE LTD. - 506285 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In furtherance to our letter dated June 03, 2022 pursuant to Regulation 30 read with part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, disclosure of the audio/ video recording of the Investor Meet held on June 03, 2022 has been made on the website of the Company at https://www.bayer.in/en/investors/investor-presentation Kindly take note of the same. BAYER CROPSCIENCE LTD. - 506285 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the presentation that will be made at the Investor Meet of Bayer CropScience Limited being held on Friday, June 03, 2022. BAYER CROPSCIENCE LTD. - 506285 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please take note that the Investor Meet of Bayer CropScience Limited is scheduled to be held on Friday, June 03, 2022 at 04:00 p.m. IST and the presentation for the same will be uploaded before the start of the said Investor Meet. BAYER CROPSCIENCE LTD. - 506285 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual Fund BAYER CROPSCIENCE LTD. - 506285 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, read with Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, the Secretarial Compliance Report of the Company, issued by M/s. BNP & Associates., Practicing Company Secretaries for the year ended March 31, 2022. Q4FY22 Quarterly Result Announced for Bayer Cropscience Ltd.
Agrochemicals firm Bayer Cropscience declares Q4FY22 result: FY 2021-22: Revenue from Operations of Rs 47,344 million and Profit Before Exceptional Items & Tax of Rs 7,883 million Q4 2021-22: Revenue from Operations of Rs 9,633 million and Profit Before Exceptional Items & Tax of Rs 1,895 million Revenue from Operations of Rs 47,344 million, compared to Rs 42,613 million in the previous year, registering an overall revenue growth of 11%. Profit Before Exceptional Items & Tax stood at Rs 7,883 million, compared to Rs 7,894 million in the previous year. Profit after Exceptional Items & Tax increased by 31% from Rs 4,931 million to Rs 6,453 million. In Q4 of FY 2021-22, the Company registered Revenue from Operations of Rs 9,633 million, compared to Rs 7,337 million in the corresponding quarter of the previous year, delivering a strong growth of 31%. Profit Before Exceptional Items & Tax for the quarter stood at Rs 1,895 million, compared to Rs 735 million in the corresponding quarter of the previous year. Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “New product launches such as Vayego and Dekalb 9208 and overall strong crop sentiments were key drivers for our sales growth in Q4. This has been achieved overcoming some supply constraints faced during the quarter and partially offsetting inflationary pressure with price increases.” Speaking on the FY results, Simon Britsch, Chief Financial Officer, Bayer CropScience Limited said, “Effective demand generation, scaling up of alternate business models and new product launches, enabled us to post strong growth of 11% in Revenue from Operations. Our operating costs increases were driven by our continuing investments into strategic initiatives to expand Bayer’s farmer reach of our portfolio and normalization of business activities as travel restrictions eased. During the year, the Company had an exceptional income of Rs 585 million arising from the sale of part of the seed distribution business viz. mustard, cotton, millet and sorghum seeds. The Board of Directors has recommended a final dividend payment of Rs 25/- per equity share of Rs 10/- each for the financial year ended March 31, 2022, subject to shareholders’ approval.” Result PDF